Ibrahim Jalal - Hikma Pharmaceuticals Insider

Hikma Pharmaceuticals PLC -- UK Stock  

GBp 1,080  20  1.89%

Sr. Corporate VP of Technical Affairs

Dr. Ibrahim Jalal is Senior Corporationrationrate Vice President Technical Affairs of Hikma Pharmaceuticals Plc. Ibrahim joined Hikma as Technical Director and has held a variety of roles including Corporationrationrate Technical Vice President for Compliance and Senior Corporationrationrate Vice President for RD. He has played a leading role in Hikma securing FDA approval for its manufacturing units. Ibrahim holds a PhD in Pharmacy from the University of WisconsinMadison.
  VP Since 2008  Ph.D    
44 20 7399 2760  http://www.hikma.com

Management Efficiency

The company has return on total asset (ROA) of 4.71 % which means that it generated profit of $4.71 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 6.97 % meaning that it generated $6.97 on every $100 dollars invested by stockholders.
The company has accumulated 880 M in total debt with debt to equity ratio (D/E) of 35.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Hikma Pharmaceuticals PLC has Current Ratio of 1.86 which is within standard range for the sector.

Entity Summary

Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of branded and nonbranded generic and inlicensed pharmaceutical solutions in solid, semisolid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, Europe, the United Kingdom, and internationally. Hikma Pharmaceuticals PLC (HIK) is traded on London Stock Exchange in UK. It is located in London, WS HW and employs 7,189 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Hikma Pharmaceuticals PLC to your portfolio

Top Management

Hikma Pharmaceuticals Leadership Team
Fadi Nassar, President
Bassam Kanaan, Executive, CPA
Khalid Nabilsi, CFO, CPA
Hussein Arkhagha, Executive
Susan Ringdal, President, MBA
Pamela Kirby, Director, Ph.D
John Castellani, Director
Brian Hoffman, President, MBA
Ali AlHusry, Director, MBA
Jochen Gann, Director
Peter Speirs, Executive
Patrick Butler, Director
Said Darwazah, Chairman, MBA
Michael Raya, CEO
Ronald Goode, Director
Breffni Byrne, Director
Nina Henderson, Director
Ragheb AlShakhshir, President
Michael Ashton, Director, MBA
Majda Labadi, President
Ibrahim Jalal, VP, Ph.D
Riad Mishlawi, President
Robert Pickering, Director
Mazen Darwazah, Chairman
HE Darwazah, Founder

Stock Performance

Hikma Pharmaceuticals Performance Indicators